Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jaeger-Ruckstuhl CA"'
Autor:
Jaeger-Ruckstuhl CA; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Specht JM; University of Washington, Seattle, Washington, United States., Voutsinas JM; Fred Hutchinson Cancer Center, Seattle, WA, United States., MacMillan HR; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Wu QV; Fred Hutchinson Cancer Center, Seattle, WA, United States., Muhunthan V; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Berger C; Fred Hutchinson Cancer Center, Seattle, WA, United States., Pullarkat S; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Wright JH; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Yeung CCS; Fred Hutchinson Cancer Center, Seattle, WA, United States., Hyun TS; Fred Hutchinson Cancer Center, Seattle, WA, United States., Seaton B; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Aicher LD; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Song X; Fred Hutchinson Cancer Center, Seattle, WA, United States., Pierce RH; Brown University, Port Townsend, WA, United States., Lo Y; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Cole GO; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Lee SM; University of Washington, Seattle, WA, United States., Newell EW; Fred Hutchinson Cancer Center, Seattle, United States., Maloney DG; Fred Hutchinson Cancer Center, Seattle, WA, United States., Riddell SR; Fred Hutchinson Cancer Center, Seattle, WA, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 28. Date of Electronic Publication: 2024 Oct 28.
Autor:
Pullarkat S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Black G; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Bleakley M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.; Program in Immunology, University of Washington, Seattle, Washington, United States of America., Buenrostro D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Program in Immunology, University of Washington, Seattle, Washington, United States of America., Chapuis AG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Program in Immunology, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America., Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America., Jaeger-Ruckstuhl CA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Kimble EL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America., Lee BM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Maloney DG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America., Radich J; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Seaton BW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Specht JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America., Turtle CJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States of America., Woolston DW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Wright JH; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Program in Immunology, University of Washington, Seattle, Washington, United States of America., Yeung CCS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Publikováno v:
PloS one [PLoS One] 2024 Jun 06; Vol. 19 (6), pp. e0303057. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).
Autor:
Jaeger-Ruckstuhl CA; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Electronic address: cjaeger@fredhutch.org., Lo Y; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Fulton E; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Waltner OG; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Shabaneh TB; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Simon S; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Muthuraman PV; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Correnti CE; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Newsom OJ; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Engstrom IA; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kanaan SB; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Bhise SS; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Peralta JMC; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Ruff R; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Seattle Children's Hospital, Seattle, WA 98105, USA., Price JP; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Seattle Children's Hospital, Seattle, WA 98105, USA., Stull SM; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Stevens AR; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Bugos G; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kluesner MG; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Voillet V; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Muhunthan V; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Morrish F; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Olson JM; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Seattle Children's Hospital, Seattle, WA 98105, USA., Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Statistics, University of Washington, Seattle, WA 98195, USA; Swiss Institute of Bioinformatics, University of Lausanne and Lausanne University Hospital, Lausanne 1011, Switzerland., Sarthy JF; Seattle Children's Hospital, Seattle, WA 98105, USA; Basic Science Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Henikoff S; Basic Science Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Sullivan LB; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Furlan SN; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Seattle Children's Hospital, Seattle, WA 98105, USA., Riddell SR; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98195, USA. Electronic address: sriddell@fredhutch.org.
Publikováno v:
Immunity [Immunity] 2024 Feb 13; Vol. 57 (2), pp. 287-302.e12.
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity.
Autor:
Shabaneh TB; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Stevens AR; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Stull SM; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Shimp KR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Seaton BW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Gad EA; Comparative Medicine, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Jaeger-Ruckstuhl CA; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Simon S; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Koehne AL; Experimental Histopathology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Price JP; Molecular Design and Therapeutics, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Olson JM; Molecular Design and Therapeutics, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hoffstrom BG; Antibody Technology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Jellyman D; Antibody Technology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Riddell SR; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA sriddell@fredhutch.org.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Feb 07; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 07.
Autor:
Miller CP; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, United States; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States. Electronic address: cpmiller@uw.edu., Fung M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Jaeger-Ruckstuhl CA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Xu Y; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Warren EH; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, United States; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, United States., Akilesh S; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States; Kidney Research Institute, University of Washington, Seattle, WA, United States., Tykodi SS; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, United States; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2023 Dec; Vol. 46, pp. 100948. Date of Electronic Publication: 2023 Nov 07.
Autor:
Naef P; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.; Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern 3008, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern 3012, Switzerland., Radpour R; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.; Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern 3008, Switzerland., Jaeger-Ruckstuhl CA; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.; Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern 3008, Switzerland., Bodmer N; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.; Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern 3008, Switzerland., Baerlocher GM; Laboratory for Hematopoiesis and Molecular Genetics, Experimental Hematology, Department of BioMedical Research (DBMR), University of Bern, Bern 3008, Switzerland., Doehner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm 89081, Germany., Doehner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm 89081, Germany., Riether C; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.; Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern 3008, Switzerland., Ochsenbein AF; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.; Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern 3008, Switzerland.
Publikováno v:
Science signaling [Sci Signal] 2023 Aug 29; Vol. 16 (800), pp. eadd7705. Date of Electronic Publication: 2023 Aug 29.
Autor:
Srivastava S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: ssrivas2@fredhutch.org., Furlan SN; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA., Jaeger-Ruckstuhl CA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Sarvothama M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Berger C; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Smythe KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Garrison SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Specht JM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA., Lee SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA., Amezquita RA; Vaccine and Infections Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Voillet V; Vaccine and Infections Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Muhunthan V; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Yechan-Gunja S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Pillai SPS; Department of Comparative Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Rader C; Department of Immunology and Microbiology, Scripps Research Institute, Jupiter, FL, USA., Houghton AM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Pierce RH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Gottardo R; Vaccine and Infections Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA., Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
Publikováno v:
Cancer cell [Cancer Cell] 2021 Feb 08; Vol. 39 (2), pp. 193-208.e10. Date of Electronic Publication: 2020 Dec 24.
Autor:
Jaeger-Ruckstuhl CA; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, 3012, Switzerland.; Program in Immunology, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, 98109, USA., Hinterbrandner M; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, 3012, Switzerland., Höpner S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland., Correnti CE; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, 98109, USA., Lüthi U; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland., Friedli O; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, 3012, Switzerland.; Institute of Pathology, University of Bern, Bern, 3008, Switzerland., Freigang S; Institute of Pathology, University of Bern, Bern, 3008, Switzerland., Al Sayed MF; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, 3012, Switzerland., Bührer ED; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, 3012, Switzerland., Amrein MA; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, 3012, Switzerland., Schürch CM; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland.; Institute of Pathology, University of Bern, Bern, 3008, Switzerland., Radpour R; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland., Riether C; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland., Ochsenbein AF; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland. adrian.ochsenbein@insel.ch.; Department of BioMedical Research (DBMR), University of Bern, Bern, 3008, Switzerland. adrian.ochsenbein@insel.ch.
Publikováno v:
Nature communications [Nat Commun] 2020 Apr 02; Vol. 11 (1), pp. 1632. Date of Electronic Publication: 2020 Apr 02.
Autor:
Correnti CE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Hallinan JP; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Doyle LA; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Ruff RO; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Jaeger-Ruckstuhl CA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Xu Y; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Shen BW; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Qu A; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Polkinghorn C; Department of Biology, Seattle University, Seattle, WA, USA., Friend DJ; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Bandaranayake AD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Kaiser BK; Department of Biology, Seattle University, Seattle, WA, USA. kaiserb@seattleu.edu., Stoddard BL; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. bstoddar@fredhutch.org., Bradley P; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. pbradley@fredhutch.org.; Program in Computational Biology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. pbradley@fredhutch.org.
Publikováno v:
Nature structural & molecular biology [Nat Struct Mol Biol] 2020 Apr; Vol. 27 (4), pp. 342-350. Date of Electronic Publication: 2020 Mar 23.